Isaac Zacharias Sells 3,370 Shares of ShockWave Medical, Inc. (NASDAQ:SWAV) Stock

ShockWave Medical, Inc. (NASDAQ:SWAVGet Rating) insider Isaac Zacharias sold 3,370 shares of ShockWave Medical stock in a transaction that occurred on Tuesday, April 26th. The shares were sold at an average price of $183.76, for a total transaction of $619,271.20. Following the sale, the insider now owns 65,840 shares of the company’s stock, valued at $12,098,758.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Isaac Zacharias also recently made the following trade(s):

  • On Monday, March 28th, Isaac Zacharias sold 4,000 shares of ShockWave Medical stock. The shares were sold at an average price of $188.83, for a total transaction of $755,320.00.
  • On Tuesday, February 15th, Isaac Zacharias sold 4,000 shares of ShockWave Medical stock. The shares were sold at an average price of $149.96, for a total transaction of $599,840.00.
  • On Wednesday, February 2nd, Isaac Zacharias sold 1,617 shares of ShockWave Medical stock. The stock was sold at an average price of $153.63, for a total transaction of $248,419.71.

NASDAQ:SWAV opened at $160.27 on Friday. The company has a fifty day moving average of $183.92 and a 200 day moving average of $182.60. ShockWave Medical, Inc. has a 52 week low of $125.00 and a 52 week high of $249.73. The company has a quick ratio of 4.71, a current ratio of 5.54 and a debt-to-equity ratio of 0.05. The firm has a market capitalization of $5.71 billion, a P/E ratio of -534.23 and a beta of 1.30.

ShockWave Medical (NASDAQ:SWAVGet Rating) last issued its quarterly earnings data on Thursday, February 17th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.07 by $0.27. The business had revenue of $84.18 million for the quarter, compared to the consensus estimate of $75.27 million. ShockWave Medical had a negative net margin of 3.85% and a negative return on equity of 4.18%. During the same period in the previous year, the firm earned ($0.46) EPS. As a group, analysts anticipate that ShockWave Medical, Inc. will post 1.47 EPS for the current year.

SWAV has been the subject of a number of recent research reports. Piper Sandler lowered their price objective on shares of ShockWave Medical from $272.00 to $245.00 in a report on Friday, February 18th. Morgan Stanley lowered their price objective on shares of ShockWave Medical from $210.00 to $199.00 and set an “equal weight” rating for the company in a report on Friday, February 18th. Canaccord Genuity Group lowered their price objective on shares of ShockWave Medical from $258.00 to $198.00 in a report on Friday, February 18th. SVB Leerink boosted their price objective on shares of ShockWave Medical from $160.00 to $190.00 and gave the stock an “outperform” rating in a report on Friday, February 18th. Finally, TheStreet upgraded shares of ShockWave Medical from a “d” rating to a “c” rating in a report on Monday, March 7th. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, ShockWave Medical currently has an average rating of “Buy” and a consensus price target of $220.33.

Institutional investors have recently modified their holdings of the business. Sittner & Nelson LLC increased its position in ShockWave Medical by 7.0% during the 3rd quarter. Sittner & Nelson LLC now owns 2,140 shares of the company’s stock valued at $441,000 after purchasing an additional 140 shares during the period. Duality Advisers LP purchased a new position in ShockWave Medical during the 4th quarter valued at $387,000. Strs Ohio increased its position in ShockWave Medical by 3.5% during the 4th quarter. Strs Ohio now owns 8,800 shares of the company’s stock valued at $1,569,000 after purchasing an additional 300 shares during the period. CIBC Asset Management Inc increased its position in ShockWave Medical by 11.0% during the 3rd quarter. CIBC Asset Management Inc now owns 1,425 shares of the company’s stock valued at $293,000 after purchasing an additional 141 shares during the period. Finally, Prospera Financial Services Inc increased its position in ShockWave Medical by 17.0% during the 3rd quarter. Prospera Financial Services Inc now owns 6,118 shares of the company’s stock valued at $1,260,000 after purchasing an additional 887 shares during the period. 93.15% of the stock is currently owned by institutional investors and hedge funds.

ShockWave Medical Company Profile (Get Rating)

ShockWave Medical, Inc, a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD.

Recommended Stories

Insider Buying and Selling by Quarter for ShockWave Medical (NASDAQ:SWAV)

Receive News & Ratings for ShockWave Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ShockWave Medical and related companies with MarketBeat.com's FREE daily email newsletter.